We would like to draw your attention to contradictory statements in relation to our work (references 1 and 2 in this letter Z ,5 t-,o correspond to references 12 and 11 in the review by K. Herman-,~ sen) reported in a recent review published in Diabetologia [3] . ~ Indeed, Dr. Hermansen quoted our results correctly by stating that c5 neurotensin "inhibited D cell secretion during stimulation with ~ very high glucose concentration (23 mmol/1)", and by referring to our work [2] among other references when he wrote that "gluca-O gon has consistently been reported to stimulate pancreatic somatotO \ statin secretion." However, quoting the same references [1, 2], Dr. Hermansen contended that "since the D cells (of our preparation) of isolated islets were unresponsive to variations in glucose from 3 to 23 mmol/1, and to the addition of 2 ~tg/ml glucagon, the results must be viewed cautiously". This is inconstistent not only with our data [1, 2] but also with what Dr. Hermansen wrote in his review. Therefore, the contention that "the results must be viewed cautiously" is not warranted and is based on misinterpretation of the data (Fig. 1 ).
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Visual Flicker Discrimination in Diabetes
Dear Sir, One simple means of quantitatively estimating the effect of diabetic complications on visual function is the evaluation of visual acuity. The intent of our efforts has been to develop a sensitive auxilliary method to evaluate another aspect of diabetic vision. We have completed a preliminary study in which measures of visual flicker discrimination were employed. Because diabetics have poorer colour vision than the general population and the deterioration tends to affect the ability to discriminate between blue and other colours [1, 2] , we developed an optic stimulator which provides either primarily a blue or a red stimulus. Our objective was to determine whether flicker discrimination using blue light would be a more sensitive indicator of impairment than would that with re~t light. The visual test field of our apparatus consisted of a background area (8 ~ by 8 ~ ) with a centrally embedded red (660 nm) light-emitting diode which subtended 3/4 ~ A white light source produced illumination for the background and either a red (approximately 660 nm) or blue (approximately 480 nm) colour could be imparted to it by placement of filters between the eye and the background. Our method for determining the critical flicker fusion frequency (i. e. that frequency at which a flickering light will just appear solid) has been described previously [3] . Here, however, the procedure was done with a blue background as well as with a red background. Control values were obtained from 20 non-diabetic patients (40 eyes). Twenty-eight diabetic patients (54 eyes) attending the diabetic clinic were studied. All subjects were less than 61 years old, with the mean age of the control group (36_+10 years) less than that of the diabetic group (47_+13 years). About 80% of the patients were taking insulin. Mid-morning post-prandial plasma glucose values were available for 23 patients with mean _+ SD of 239 18.0 _+ 6.5 mmol/1. Glycosylated haemoglobin values were available for 10 patients with a range of 7.3 to 13.4% A 1 and mean _+ SD of 10.2 + 2.1%. From the ophthalmological findings, corrected visual acuity ranged from 20/20 to 20/80 with average acuity of better than 20/30. A comparison of the diabetic and control eyes studied is shown in the scattergram (Fig. 1) . Eight of the eyes studied showed an abnormal flicker discrimination with the blue backgroUnd condition but not with the red background condition. For the most part, if an abnormality existed it involved both colours. A classification scheme with four groups was established as follows: 1) normal (a group of 26 eyes with no abnormal findings by fundoscopy); 2) background retinopathy (a group of 15 eyes with evidence of mild vascular changes with or without hard or soft exudates or oedema); 3) cataract (a group of six eyes with evidence of cataract within the lens); and 4) complex lesions (a group of seven eyes with cataract plus background changes, or proliferative retinopathy, or laser treatment). As shown in Table 1 , an eye with normal findings by fundoscopy can show abnormal flicker discrimination.
Our preliminary results indicate that measures of flicker discrimination can present evidence of impairment when other findings are normal. The impairment is more often evident when blue light is used. Further study of flicker discrimination using blue light might determine whether 1) loss of the blue response is associated with damage to specific retinal areas as demonstrated by fluorescein angiography and 2) a relationship exists between diabetic regulation and critical fusion frequency changes which occur over a period of months. 
